Ks logo

News & Insights

Subscribe
Icon search Icon close

  • People
  • OfficesIcon submenu
    • Icon submenu back back
    • Offices
    • North AmericaIcon submenu
      • Icon submenu back back
      • North America
      • Atlanta
      • Austin
      • Charlotte
      • Chicago
      • Denver
      • Houston
      • Los Angeles
      • Miami
      • New York
      • Northern Virginia
      • San Francisco
      • Silicon Valley
      • Washington, D.C.
    • Europe & Middle EastIcon submenu
      • Icon submenu back back
      • Europe & Middle East
      • Abu Dhabi
      • Brussels
      • Dubai
      • Frankfurt
      • Geneva
      • London
      • Paris
    • AsiaIcon submenu
      • Icon submenu back back
      • Asia
      • Singapore
      • Tokyo
  • CapabilitiesIcon submenu
    • Icon submenu back back
    • Capabilities
    • Corporate, Finance and InvestmentsIcon submenu
      • Icon submenu back back
      • Corporate, Finance and Investments
      • Overview
      • Activist Defense
      • Banking and Institutional Finance
      • Capital Markets
      • Construction and Procurement
      • Corporate Governance
      • Emerging Companies and Venture Capital
      • Employee Benefits and Executive Compensation
      • Energy and Infrastructure Projects
      • Financial Restructuring
      • Global Human Capital and Compliance
      • Investment Funds and Asset Management
      • Mergers and Acquisitions (M&A)
      • Middle East and Islamic Finance and Investment
      • Private Credit & Special Situations
      • Private Equity
      • Public Companies
      • Real Estate
      • Structured Finance and Securitization
      • Tax
      • Technology Transactions
    • Government MattersIcon submenu
      • Icon submenu back back
      • Government Matters
      • Overview
      • Antitrust
      • Data, Privacy and Security
      • Environmental, Health and Safety
      • FDA and Life Sciences
      • Government Advocacy and Public Policy
      • Government Contracts
      • Healthcare
      • International Trade
      • National Security and Corporate Espionage
      • Securities Enforcement and Regulation
      • Special Matters and Government Investigations
    • Trial and Global DisputesIcon submenu
      • Icon submenu back back
      • Trial and Global Disputes
      • Overview
      • Antitrust
      • Appellate, Constitutional and Administrative Law
      • Bankruptcy and Insolvency Litigation
      • Class Action Defense
      • Commercial Litigation
      • Construction and Engineering Disputes
      • Corporate and Securities Litigation
      • E-Discovery
      • Intellectual Property
      • International Arbitration and Litigation
      • Labor and Employment
      • Product Liability
      • Professional Liability
      • Toxic & Environmental Torts
    • Industries / IssuesIcon submenu
      • Icon submenu back back
      • Industries / Issues
      • Industries
      • Automotive, Transportation and Mobility
      • Energy
      • Financial Services
      • Food and Beverage
      • Higher Education
      • Life Sciences and Healthcare
      • Technology
      • Issues
      • #MeToo
      • Buy American
      • COVID-19 Vaccine Rollout
      • Crisis Management
      • Environmental Agenda
      • Environmental, Social and Governance (ESG)
      • Focus on Women's Health
      • Russia/Ukraine
      • Special Purpose Acquisition Companies (SPACs)
  • CareersIcon submenu
    • Icon submenu back back
    • Careers
    • LawyersIcon submenu
      • Icon submenu back back
      • Lawyers
      • Experienced Lawyers
    • StudentsIcon submenu
      • Icon submenu back back
      • Students
      • Law Students
      • UK Graduate Recruitment
    • Judicial ClerksIcon submenu
      • Icon submenu back back
      • Judicial Clerks
      • Judicial Clerks
    • Other ProfessionalsIcon submenu
      • Icon submenu back back
      • Other Professionals
      • Other Professionals
  • News & InsightsIcon submenu
    • Icon submenu back back
    • News & Insights
    • NewsIcon submenu
      • Icon submenu back back
      • News
      • Cases & Deals
      • In the News
      • Press Releases
      • Recognitions
    • EventsIcon submenu
      • Icon submenu back back
      • Events
      • Conferences
      • Speaking Engagements
      • Webinars
    • InsightsIcon submenu
      • Icon submenu back back
      • Insights
      • Newsletters
      • Client Alerts
      • Thought Leadership
      • Articles
      • Feature
      • BLOGS
      • Auditor Liability Bulletin
      • COVID-19 Vaccine Updates
      • ESG Excellence
  • AboutIcon submenu
    • Icon submenu back back
    • About
    • Our FirmIcon submenu
      • Icon submenu back back
      • Our Firm
      • History
      • Our Values
    • Diversity & InclusionIcon submenu
      • Icon submenu back back
      • Diversity & Inclusion
      • Overview
      • Women’s Initiatives
      • Racial Diversity
      • LBGTQ+ Affinity
    • CitizenshipIcon submenu
      • Icon submenu back back
      • Citizenship
      • Overview
      • Pro Bono
      • Community Focus
  • Languages

News & Insights

  • NewsIcon submenu
    • Icon submenu back back
    • News
    • Cases & Deals
    • In the News
    • Press Releases
    • Recognitions
  • EventsIcon submenu
    • Icon submenu back back
    • Events
    • Conferences
    • Speaking Engagements
    • Webinars
  • InsightsIcon submenu
    • Icon submenu back back
    • Insights
    • Newsletters
    • Client Alerts
    • Thought Leadership
    • Articles
    • Feature
    • BLOGS
    • Auditor Liability Bulletin
    • COVID-19 Vaccine Updates
    • ESG Excellence
< Back to Bio
Icon close orange Ruth M.D. Byrne, K.C.

News 25 results

Recognition

March 31, 2023
King & Spalding Once Again Earns Top Spot on Global Arbitration Review’s GAR 30 Ranking

Recognition

February 16, 2023
King & Spalding Earns Strong Rankings in Chambers Global 2023 Results

In the News · Source: Law360

November 8, 2022
Ruth Byrne KC and Kabir Bhalla represent GW Pharma in a dispute involving unpaid royalties for a seizure treatment

Recognition

November 8, 2022
Legal 500 Names Tom Sprange KC to its International Arbitration Powerlist UK 2022

Recognition

October 20, 2022
King & Spalding Receives Multiple Rankings in Chambers UK 2023 Guide

Recognition

September 29, 2022
King & Spalding Earns Multiple Rankings in Legal 500 UK 2023 Guide

Cases & Deals

July 12, 2022
King & Spalding Supports JUSTICE Working Party On Hybrid Orders

Recognition

April 4, 2022
King & Spalding Named Top International Arbitration Practice Worldwide

Cases & Deals

February 28, 2022
King & Spalding advises JUSTICE on response to UK’s proposed human rights overhaul

Recognition

February 18, 2022
Chambers Global 2022 Recognizes King & Spalding as a Leading International Law Firm

Recognition

December 22, 2021
Ruth Byrne Appointed to Queen’s Counsel 2021 List

In the News · Source: Law.com International, The Global Legal Post, The Law Society Gazette, Legal Business, The Lawyer, Global Arbitration Review and Legal Era

December 22, 2021
Ruth Byrne has been appointed Queen’s Counsel in the 2021 QC list

© 2023 King & Spalding LLP
  • Contact Us
  • Disclaimer
  • Privacy Notice
  • Transparency Disclosure
  • Cookie Policy
  • Copyright Notice
  • Regulatory Notices
  • CPRA Privacy Notice
  • K&S Alumni Group